Nitric oxide-mediated activity in anti-cancer photodynamic therapy

Nitric Oxide - Biology and Chemistry

Volumn 30, Issue , 2013, Pages 26-35

  Rapozzi, Valentina ^a   Della Pietra, Emilia ^a   Zorzet, Sonia ^b   Zacchigna, Marina ^b   Bonavida, Benjamin ^c   Xodo, Luigi Emilio ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

B78 H1 amelanotic melanoma; C57BL 6 mice; DETANONOate; Nitric oxide; Pheophorbide a; Photodynamic therapy

Indexed keywords

4,5 DIAMINOFLUORESCEIN DIACETATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROGOL; NITRIC OXIDE; NITRIC OXIDE DONOR; PHEOPHORBIDE; PHEOPHORBIDE ALPHA; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG;

AMELANOTIC MELANOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; C57BL 6 MOUSE; CANCER THERAPY; CELL GROWTH; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; DRUG HALF LIFE; FEMALE; GENE EXPRESSION; GENE PRODUCT; MOUSE; NONHUMAN; PHOTOACTIVATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TUMOR GROWTH; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; CHLOROPHYLL; FEMALE; FLOW CYTOMETRY; MELANOMA, AMELANOTIC; MICE; MICE, INBRED C57BL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROSO COMPOUNDS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS; WOUND HEALING;

GASTROPODA; MURINAE; MUS;

EID: 84873728416     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2013.01.002     Document Type: Article

References (62)

1. T.J. Dougherty, C.J. Gomer, B.W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and Q. Peng Photodynamic therapy J. Natl. Cancer Inst. 90 1998 889 905
2. P. Agostinis, K. Berg, K.A. Cengel, T.H. Foster, A.W. Girotti, S.O. Gollnick, S.M. Hahn, M.R. Hamblin, A. Juzeniene, D. Kessel, M. Korbelik, J. Moan, P. Mroz, D. Nowis, J. Piette, B.C. Wilson, and J. Golab Photodynamic therapy of cancer: an update CA Cancer J. Clin. 4 2011 250 281
3. C.J. Gomer, A. Ferrario, M. Luna, N. Rucker, and S. Wong Photodynamic therapy: combined modality approaches targeting the tumor microenvironment Lasers Surg. Med. 38 2006 516 521
4. A. Ferrario, K. von Tiehl, S. Wong, M. Luna, and C.J. Gomer Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy mediated tumor response Cancer Res. 62 2002 3956 3961
5. A. Ferrario, C.F. Chantrain, K.F. von Thiel, S. Buckley, N. Rucker, D.R. Shalinsky, H. Shimada, Y.A. DeClerck, and C.J. Gomer The matrix metalloproteinase inhibitor prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model Cancer Res. 64 2004 2328 2332
6. A. Ferrario, N. Rucker, S. Wong, M. Luna, and C.J. Gomer Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response Cancer Res. 67 2007 4989 4995
7. I. Coupienne, S. Bontems, M. Dewaele, N. Rubio, Y. Habraken, S. Fulda, P. Agostinis, and J. Piette NF-kappaB inhibition improves the sensitivity of human glioblastoma cells to 5-aminolevulinic acid-based photodynamic therapy Biochem. Pharmacol. 8 2011 606 616
8. A.P. Castano, P. Mroz, and M.R. Hamblin Photodynamic therapy and anti-tumour immunity Nat. Rev. Cancer 6 2006 535 545
9. P.K. Lala, and C. Chakraborty Role of nitric oxide in carcinogenesis and tumour progression Lancet Oncol. 3 2001 149 156
10. D. Hirst, and T. Robson Targeting nitric oxide for cancer therapy J. Pharm. Pharmacol. 59 2007 3 13
11. S. Mocellin, V. Bronte, and D. Nitti Nitric oxide, a double-edged sword in cancer biology: searching for therapeutic opportunities Med. Res. Rev. 27 2007 317 352
12. D.A. Wink, and J.B. Mitchell Chemical biology of nitric oxide: insights into the regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide Free Radic. Biol. Med. 25 1998 434 456
13. S.R. Moncada, R.M.J. Palmer, and E.A. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol. Rev. 43 1991 109 143
14. S.D. Cline, J.N. Riggins, S. Tornaletti, L.J. Marnett, and P.C. Hanawalt Malondialdehyde adducts in DNA-arrest transcription by T7 RNA polymerase and mammalian RNA polymerasse II Proc. Natl. Acad. Sci. USA 101 2004 7275 7280
15. J.D. West, J.C. Duncan, S.T. Amarnath, V. Schneider, C. Rizzo, C.J. Brash, and L.J. Marnett Induction of apoptosis in colorectal carcinoma cells treated with 4-hydroxy-2-nonenal and structurally related aldehydic products of lipid peroxidation Chem. Res. Toxicol. 17 2004 453 462
16. M. Korbelik, C.S. Parkins, H. Shibuya, I. Cecic, M.R. Stratford, and D.J. Chaplin Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy Br. J. Cancer 82 2000 1835 1843
17. K.J. Reeves, M.W.R. Reed, and N.J. Brown Is nitric oxide important in photodynamic therapy? J. Photochem. Photobiol. B 95 2009 141 147
18. S. Gupta, N. Ahmad, and H. Mukhtar Involvment of nitric oxide during phthalocyanine (Pc4) photodynamic therapy-mediated apoptosis Cancer Res. 58 1998 1785 1788
19. T.B. McCall, N.K. Boughton-Smith, R.M. Palmer, B.J. Whittle, and S. Mocada Synthesis of nitric oxide from l-arginine by neutrophils. Release and interaction with superoxide anion Biochem. J. 261 1989 293 296
20. J. Mehta, D.L. Lawson, F.A. Nicolini, M.H. Ross, and D.W. Player Effects of activated polymorphonuclear leukocytes on vascular smooth muscle tone Am. J. Physiol. 261 1991 H327 H334
21. T.J. Evans, L.D.K. Buttery, A. Carpenter, D.R. Springall, J.M. Polak, and J. Cohen Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria Proc. Natl. Acad. Sci. USA 93 1996 9553 9558
22. L.K. Keefer, R.W. Nims, K.M. Davies, and D.A. Wink NONOates (1-substituted diazen-1-ium-1,2-diolates) as nirtric oxide donors: convenient nitric oxide dosage form Methods Enzymol. 268 1996 281 293
23. B. Bonavida, S. Baritaki, S. Huerta-Yepez, M.I. Vega, D. Chatterjee, and K. Yeung Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastases Nitric Oxide 19 2008 152 157
24. B. Bonavida, and S. Baritaki Dual role of NO donors in the reversal of tumor cell resistance and EMT: downregulation of the NF-κB/Snail/YY1/RKIP circuitry Nitric Oxide 24 2011 1 7
25. D. Fukumura, S. Kashiwagi, and R.K. Jain The role of nitric oxide in tumor progression Nat. Rev. Cancer 6 2006 521 534
26. N.L. Reynaert, K. Ckless, S.H. Korn, N. Vos, A.S. Guala, E.F. Wouters, A. van der Vliet, and Y.M. Janssen-Heininger Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation Proc. Natl. Acad. Sci. USA 101 2004 8945 8950
27. S. Baritaki, S. Huerta-Yepez, A. Sahakyan, I. Karagiannides, K. Bakirtzi, A. Jazirehi, and B. Bonavida Mechanisms of nitric oxide-mediated inhibition of EMT in cancer: inhibition of the metastasis-inducer Snail and induction of the metastasis-suppressor RKIP Cell Cycle 9 2010 4931 4940
28. V. Rapozzi, K. Umezawa, and L.E. Xodo Role of NF-κB/Snail/RKIP loop in the response of tumor cells to photodynamic therapy Lasers Surg. Med. 43 2011 575 585
29. G.M. Bonora, P. Campaner, and S. Drioli Synthesis of selectively end-modified high-molecular weight polyethylenglycole Lett. Org. Chem. 3 2006 773 779
30. X. Gao, D. Saha, P. Kapur, T. Anthony, E.H. Livingston, and S. Huerta Radiosensitization of HT-29 cells and xenografts by the nitric oxide donor DETANONOate J. Surg. Oncol. 100 2009 149 158
31. M.F. Zuluaga, and N. Lange Combination of photodynamic therapy with anti-cancer agents Curr. Med. Chem. 15 2008 1655 1673
32. A. Vogt Advances in two-dimensional cell migration assay technologies Eur. Pharm. Rev. 5 2010 26 29
33. H. Kojima, K. Sakurai, K. Kikuchi, S. Kawahara, Y. Kirino, H. Nagashi, Y. Hirata, and T. Nagano Development of a fluorescent indicator for nitric oxide based on the fluorescein chromophore Chem. Pharm. Biol. 46 1998 373 375
34. H. Kojima, N. Nakatsubo, K. Kikuchi, S. Kawahara, Y. Kirino, H. Nagashi, Y. Hirata, and T. Nagano Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins Anal. Chem. 70 1998 2446 2453
35. H. Koijma, Y. Urano, K. kikuchi, T. Higuchi, Y. Hirata, and T. Nagano Fluorescent indicators for imaging nitric oxide production Angew. Chem., Int. Ed. 38 1999 3209 3212
36. M.A.K. Markwell, S.M. Haas, L.L. Bieber, and N.E. Tolbert A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples Anal. Biochem. 87 1978 206 210
37. S. Rumer, M. Krischke, A. Fekete, M.J. Mueller, and W.M. Kaiser DAF-fluorescence without NO: elicitor treated tobacco cells produce fluorescing DAF-derivatives not related to DAF-2 triazol Nitric Oxide 27 2012 123 135
38. M. Niziolek, W. Korytowski, and A.W. Girotti Nitric oxide-induced resistance to lethal photooxidative damage in a breast tumor cell line Free Radic. Biol. Med. 40 2006 1323 1331
39. R. Bhowmick, and A.W. Girotti Signaling events in apoptotic photokilling of 5-aminolevulinic acid-treated tumor cells: inhibitory effects of nitric oxide Free Radic. Biol. Med. 47 2009 731 740
40. R. Bhowmick, and A.W. Girotti Cytoprotective induction of nitric oxide synthase in a cellular model of 5-aminolevulinic acid-based photodynamic therapy Free Radic. Biol. Med. 48 2010 1296 1301
41. M. Joshi, J. Strandhoy, and W.L. White Nitric oxide synthase activity is up-regulated in melanoma cell lines: a potential mechanism for metastases formation Melanoma Res. 6 1996 121 126
42. S. Baritaki, A. Katsman, D. Chatterjee, K.C. Yeung, D.A. Spandidos, and B. Bonavida Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation J. Immunol. 179 2007 5441 5453
43. F. Al-Mulla, M.S. Bitar, J. Feng, S. Park, and K.C. Yeung A new model for raf kinase inhibitory protein induced chemotherapeutic resistance PLoS ONE 7 2012 e29532 (Epub 2012 Jan 18)
44. S. Huerta, G. Baay-Guzman, C.R. Gonzales-Bonilla, E.H. Livingston, S. Huerta-Yepez, and B. Bonavida In vitro and in vivo sensitization of SW620 metastatic colon cancer cells to CDDP-induced apoptosis by the nitric oxide donor DETANONOate: involvement of AIF Nitric Oxide 20 2009 182 194
45. V. Rapozzi, M. Miculan, and L.E. Xodo Evidence that photoactivated pheophorbide a causes in human cancer cells a photodynamic effect involving lipid peroxidation Cancer Biol. Ther. 8 2009 1318 1327
46. P.M.K. Tang, J.Y.W. Chan, S.W.N. Au, S.K. Kong, S.K.W. Tsui, M.M.Y. Waye, T.C. Mak, W.P. Fong, and K.P. Fung Pheophorbide a, an active compound isolated from Scutellaria barbata, possesses photodynamic activities by inducing apoptosis in human hepatocellular carcinoma Cancer Biol. Ther. 5 2006 1111 1116
47. V. Rapozzi, M. Zacchigna, S. Biffi, C. Garrovo, F. Cateni, M. Stebel, S. Zorzet, G.M. Bonora, S. Drioli, and L.E. Xodo Conjugated PDT drug: photosensitizing activity and tissue distribution of PEGylated pheophorbide a Cancer Biol. Ther. 10 2010 471 482
48. B.W. Henderson, and T.J. Dougherty How does photodynamic therapy work? Photochem. Photobiol. 55 1992 145 157
49. E. Buytaert, M. Dewaele, and P. Agostinis Molecular effectors of multiple cell death pathways initiated by photodynamic therapy Biochim. Biophys. Acta 1776 2007 86 107
50. G. Di Venosa, C. Perotti, H. Fukuda, A. Batlle, and A. Casas Sensitivity to ALA-PDT of cell lines with different nitric oxide production and resistance to NO cytotoxicity J. Photochem. Photobiol. B 80 2005 195 202
51. K.M. Davies, D.A. Wink, J.E. Saavedra, and L.K. Keefer Chemistry of the diazeniumdiolates. 2. Kinetics and mechanism of dissociation to nitric oxide in aqueous solution J. Am. Chem. Soc. 123 2001 5473 5481
52. G.A. Blaise, D. Gauvin, M. Cangal, and S. Authier Nitric oxide, cell signaling and cell death Toxicology 208 2005 177 192
53. D. Benz, P. Cadet, K. Mantione, W. Zhu, and G. Stefano Tonal nitric oxide and health-a free radical and a scavenger of free radicals Med. Sci. Monit. 8 2002 RA1 RA4
54. N. Tuteja, M. Chandra, R. Tuteja, and M.K. Misra Nitric oxide as a unique bioactive signaling messenger in physiology and pathophysiology J. Biomed. Biotechnol. 2004 2004 227 237
55. D.T. Hess, A. Matsumoto, S.O. Kim, H.E. Marshall, and J.S. Stanler Protein S-nitrosylation: purview and parameters Nat. Rev. Mol. Cell Biol. 6 2005 150 166
56. M. Cortier, L. Leon, N. Sassi, C. Paul, J.F. Jeannin, and A. Bettaieb Nitric oxide is a promising enhancer for cancer therapy B. Bonavida, Nitric Oxide and Cancer Prognosis, Prevention and Therapy 2010 Human Press New York 253 263
57. T. Efferth Role of nitric oxide for modulation of cancer therapy resistance B. Bonavida, Nitric Oxide and Cancer Prognosis, Prevention and Therapy 2010 Human Press New York 265 282
58. K.J. Reeves, M.W. Reed, and N.J. Brown The role of nitric oxide in the treatment of tumours with aminolaevulinic acid-induced photodynamic therapy J. Photochem. Photobiol. B 101 2010 224 232
59. M. Niziolek, W. Korytowski, and A.W. Girotti Chain-breaking antioxidant and cytoprotective action of nitric oxide on photodynamically stressed tumor cells Photochem. Photobiol. 78 2003 262 270
60. C. Li, and G.N. Wogan Nitric oxide as a modulator of apoptosis Cancer Lett. 226 2005 1 15
61. Z.T. Kelleher, A. Matsumoto, J.S. Stamler, and H.E. Marshall NOS2 regulation of NF-κB by S-nitrosylation of p65 J. Biol. Chem. 282 2007 30667 30672
62. S. Huerta-Yepez, N.K. Yoon, A. Hernandez-Cueto, V. Mah, C.M. Rivera-Pazos, D. Chatterjee, M.I. Vega, E.L. Maresh, S. Horvath, D. Chia, B. Bonavida, and L. Goodglick Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival BMC Cancer 11 2011 259 267